Skip to main content Back to Top
Advertisement

3/19/2024

Ampicillin Injection

Products Affected - Description

    • Ampicillin Sodium injection, Eugia US, 1 gram, vial, 10 count, NDC 55150-0113-10
    • Ampicillin Sodium injection, Eugia US, 2 gram, vial, 10 count, NDC 55150-0114-20
    • Ampicillin Sodium injection, Piramal Critical Care, 1 gram, vial, 10 count, NDC 66794-0222-41
    • Ampicillin Sodium injection, Piramal Critical Care, 10 gram, vial, 1 count, NDC 66794-0224-15
    • Ampicillin Sodium injection, Piramal Critical Care, 2 gram, vial, 10 count, NDC 66794-0223-41
    • Ampicillin Sodium injection, Piramal Critical Care, 250 mg, vial, 10 count, NDC 66794-0220-41
    • Ampicillin Sodium injection, Piramal Critical Care, 500 mg, vial, 10 count, NDC 66794-0221-41
    • Ampicillin Sodium injection, Sandoz, 125 mg, vial, 10 count, NDC 00781-3400-95

Reason for the Shortage

    • Armas has ampicillin 2 gram vials available.
    • Eugia did not provide a reason for the shortage.
    • Fresenius Kabi has ampicillin injection available.
    • Methapharm has not provide an update since October. Ampicillin is not currently listed on their website.
    • Piramal has ampicillin injection on shortage due to manufacturing delays.
    • Sagent has ampicillin injection available.
    • Sandoz did not provide a reason for the shortage.
    • Pfizer discontinued ampicillin 10 gram vials in October 2023.
    • Viatris discontinued their presentations in January 2023.
    • WG Critical Care has ampicillin injection available.

Available Products

    • Ampicillin Sodium injection, Armas Pharmaceuticals, 1 gram, vial, 10 count, NDC 72485-0421-10
    • Ampicillin Sodium injection, Armas Pharmaceuticals, 2 gram, vial, 10 count, NDC 72485-0422-10
    • Ampicillin Sodium injection, Eugia US, 10 gram, vial, 10 count, NDC 55150-0115-99
    • Ampicillin Sodium injection, Fresenius Kabi, 1 gram, vial, 10 count, NDC 65219-0018-20
    • Ampicillin Sodium injection, Fresenius Kabi, 2 gram, vial, 10 count, NDC 65219-0020-23
    • Ampicillin Sodium injection, Fresenius Kabi, 250 mg, vial, 10 count, NDC 65219-0014-10
    • Ampicillin Sodium injection, Fresenius Kabi, 500 mg, vial, 10 count, NDC 65219-0016-10
    • Ampicillin Sodium injection, Sagent, 1 gram, vial, 10 count, NDC 25021-0136-10
    • Ampicillin Sodium injection, Sagent, 10 gram, vial, 10 count, NDC 70860-0118-99
    • Ampicillin Sodium injection, Sagent, 2 gram, vial, 10 count, NDC 25021-0137-20
    • Ampicillin Sodium injection, Sandoz, 1 gram, ADD-Vantage vial, 10 count, NDC 00781-3412-92
    • Ampicillin Sodium injection, Sandoz, 1 gram, vial, 10 count, NDC 00781-3404-95
    • Ampicillin Sodium injection, Sandoz, 2 gram, ADD-Vantage vial, 10 count, NDC 00781-3413-92
    • Ampicillin Sodium injection, Sandoz, 2 gram, vial, 10 count, NDC 00781-3408-95
    • Ampicillin Sodium injection, Sandoz, 250 mg, vial, 10 count, NDC 00781-3402-95
    • Ampicillin Sodium injection, Sandoz, 500 mg, vial, 10 count, NDC 00781-3407-95
    • Ampicillin Sodium injection, WG Critical Care, 1 gram, vial, 10 count, NDC 44567-0102-10
    • Ampicillin Sodium injection, WG Critical Care, 10 gram, vial, 10 count, NDC 44567-0104-10
    • Ampicillin Sodium injection, WG Critical Care, 2 gram, vial, 10 count, NDC 44567-0103-10
    • Ampicillin Sodium injection, WG Critical Care, 500 mg, vial, 10 count, NDC 44567-0101-10

Estimated Resupply Dates

    • Eugia has ampicillin 1 gram and 2 gram vials on intermittent back order and the company is releasing product as it becomes available.
    • Piramal has all ampicillin presentations on back order and the company estimates a release date of May 2024.
    • Sandoz has ampicillin 125 mg vials on back order and the company cannot estimate a release date.

Updated

Updated March 19, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 23, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT